scispace - formally typeset
S

Shinya Watanabe

Researcher at Fukushima Medical University

Publications -  86
Citations -  5711

Shinya Watanabe is an academic researcher from Fukushima Medical University. The author has contributed to research in topics: Cancer & Gene. The author has an hindex of 21, co-authored 80 publications receiving 5366 citations. Previous affiliations of Shinya Watanabe include Tokyo Medical and Dental University & National Institute of Advanced Industrial Science and Technology.

Papers
More filters
Journal ArticleDOI

Genistein, a specific inhibitor of tyrosine-specific protein kinases.

TL;DR: Genistein inhibited the EGF-stimulated increase in phosphotyrosine level in A431 cells and scarcely inhibited the enzyme activities of serine- and threonine-specific protein kinases such as cAMP-dependent protein kinase, phosphorylase kinases, and the Ca2+/phospholipid-dependent enzymeprotein kinase C.
Journal ArticleDOI

NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells

TL;DR: Findings indicate that NOTCH3-mediated signaling rather than NOTCH1- mediated signaling plays an important role in the proliferation of ErbB2-negative breast tumor cells and that targeted suppression of this signaling pathway may be a promising strategy for the treatment of Er bBB 2- negative breast cancers.
Journal ArticleDOI

CD24 is expressed specifically in the nucleus pulposus of intervertebral discs.

TL;DR: CD24, a glycosylphosphatidylinositol anchor protein, was identified as a cell surface marker for NP and was detected in the herniated NP and chordoma, a malignant primary tumor derived from notochordal cells, while it was absent in chondrosarcoma.
Journal ArticleDOI

Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines

TL;DR: Results suggest that constitutive NF‐κB activation, partially dependent on NIK, is preferentially involved in proliferation of basal‐like subtype breast cancer cells and may be a useful therapeutic target for this subtype of cancer.